Bob Evans Farms
said same-store sales for March decreased 4.3% from a year ago. The company also said its average menu prices for the month were down 0.1%. The stock was down $1, or 4.48%, to $21.51 in after-hours trading.
announced the publication of results from the Phase III clinical study of Vivitrex, which showed that a once-a-month dose of the drug in combination with counseling significantly reduced the average number of heavy drinking days in alcohol-dependent patients. The stock was up 40 cents, or 3.8%, to $10.84 in the after hours.
said that it will begin to expense equity compensation when it reports its first-quarter financial results on April 18. The company also said it will restate prior-period financial results to include the impact of share-based, or option, compensation expenses. The stock was down 64 cents, or 0.7%, to $89.01 in after-hours trading.
Research in Motion
said it lost $2.6 million, or a penny a share, for the fourth quarter ended Feb. 26, compared to net income of $41.5 million, or 23 cents a share a year earlier. Excluding a charge of $294.2 million to resolve the NTP litigation and a related tax write-up of $151.6 million, net income for the quarter was $140.1 million, or 71 cents a share. Revenue for the quarter was $404.8 million. Analysts expected earnings of 65 cents a share, excluding litigation and other charges, on revenue of $410 million, according to Thomson First Call.
For the first quarter, the company said it expects to earn 51 cents to 56 cents a share on sales in the range of $430 million to $455 million, down from the 57 cents to 63 cents a share, on sales from $460 million to $485 million. The stock was down $2.97, or 3.99%, to $71.43 in after-hours trading.
said that it plans to offer about $750 million of convertible preferred stock. The offering will be made to qualified institutional buyers, the company said. The stock was down 12 cents, or 1.13%, to $10.54 in after-hours trading.